European Union

Complete guide to third-party vendor cybersecurity risk management for medical devices — FDA Section 524B, QMSR ISO 13485 alignment, SBOM requirements, vendor risk assessment frameworks, MITRE threat modeling, and implementation strategies for connected device manufacturers.

Complete guide to augmented reality and virtual reality medical device regulation — FDA classification, product codes, 510(k) vs De Novo pathways, the 104 FDA-cleared AR/VR devices, surgical navigation, therapeutic VR, and human factors requirements in 2026.

Complete career guide for medical device regulatory affairs professionals — career paths from entry level to VP, salary ranges by role and region, RAC certification details, essential skills, and how to break into the field in 2026.

How to choose between Agile and Waterfall for medical device software development under IEC 62304 — AAMI TIR45 guidance, design control mapping, hybrid models, and what auditors actually look for.

Complete guide to benefit-risk analysis for medical devices — ISO 14971:2019 residual risk evaluation, EU MDR AFAP requirements, FDA benefit-risk factors for PMA/De Novo/510(k), MDCG guidance, practical examples, and documentation best practices.

Complete guide to demonstrating clinical equivalence under EU MDR Article 61 and Annex XIV — technical, biological, and clinical characteristics per MDCG 2020-5, differences from MEDDEV 2.7/1 Rev. 4, data access requirements, gap analysis, and practical examples for CE marking.

How to select a medical device contract manufacturing organization — CMO evaluation criteria, quality agreement requirements under FDA 21 CFR 820 and ISO 13485, audit programs, change control, and step-by-step implementation checklist.

How to design and run decentralized clinical trials for medical devices — FDA final guidance, hybrid vs fully remote models, digital endpoints, wearable data capture, eConsent, and step-by-step implementation framework.

Complete guide to medical device design output documentation — what ISO 13485 Clause 7.3.4 and FDA 21 CFR 820.30(d) require for drawings, specifications, BOMs, acceptance criteria, and traceability to design inputs under QMSR.

Complete guide to medical device design review documentation — how to plan agendas, record minutes, ensure reviewer independence per FDA 21 CFR 820.30(e) and ISO 13485 Clause 7.3.5, and create audit-ready design review records under QMSR.

Complete guide to medical device design transfer — how to move from design to production under FDA 21 CFR 820.30(h), ISO 13485 Clause 7.3.8, and QMSR. Covers DMR readiness, process validation (IQ/OQ/PQ), supplier qualification, and audit-ready documentation.

Complete guide to validating Electronic Data Capture (EDC) systems for medical device clinical trials — 21 CFR Part 11 compliance, EU GMP Annex 11, ICH E6(R2)/(R3) GCP requirements, GAMP 5 risk-based validation approach, IQ/OQ/PQ methodology, audit trail requirements, ALCOA+ principles, vendor vs sponsor responsibilities, study-specific validation, and common FDA inspection findings.

Complete guide to electronic Instructions for Use (eIFU) for medical devices — EU Implementing Regulation 2021/2226 as amended by Regulation 2025/1234 expanding eIFU to all professional-use devices, risk assessment requirements, labeling obligations, EUDAMED UDI integration, FDA electronic IFU policy under 21 CFR Part 801, paper IFU fallback rules, IVDR provisions for IVDs, SaMD-specific guidance, validation expectations, and implementation checklist.

How much does it cost to register a medical device in the European Union in 2026? A buyer-side breakdown of EU Authorized Representative (EC REP) service pricing — hourly billing, registration-fee-plus-annual, and flat all-inclusive fee — with worked 3-year cash flow scenarios for MDR and IVDR portfolios.

How to perform Fault Tree Analysis under ISO 14971 for medical devices — FTA vs FMEA comparison, AND/OR gate logic, quantitative probability calculations, real-world examples, and when top-down analysis outperforms bottom-up methods.

Complete comparison of hazard analysis methods for medical device risk management — when to use FMEA, FTA, PHA, HAZOP, and use-related risk analysis under ISO 14971, IEC 62366, FDA, and EU MDR requirements, with examples and decision guidance.

Comprehensive guide to ISO/TR 24971:2020, the companion technical report to ISO 14971:2019 — how to use its annexes for hazard identification, risk analysis methods, benefit-risk analysis, cybersecurity, IVDs, and practical implementation across your risk management process.

Step-by-step guide to creating a compliant literature search protocol for medical device clinical evaluation under EU MDR Article 61 and Annex XIV — MEDDEV 2.7/1 Rev. 4 methodology, PICO framework, database selection, inclusion/exclusion criteria, critical appraisal, PRISMA documentation, and Notified Body expectations.

Guide to selecting, validating, and using patient-reported outcome (PRO) instruments in medical device clinical trials — FDA CDRH draft guidance on fit-for-purpose PROs, EU MDR clinical evaluation requirements, COA types (PRO, ClinRO, ObsRO, PerfO), instrument validation, endpoint hierarchy, and regulatory submission strategies.

Clear guide to the differences between a risk management file and risk management report under ISO 14971:2019 — what each contains, how they relate, traceability requirements, and common audit findings from notified bodies and FDA.